Targeted screening

Key testing

• CSMTU | Controlled Substance Monitoring Targeted Profile, 17 Drug Classes, Mass Spectrometry, Random, Urine
  • Identifies drug use involving amphetamines, benzodiazepines, opioids, and PCP where immunoassays are not adequate.
  • Includes specimen validity testing.
  • Results reported with interpretative comments.
• TBSU | Targeted Benzodiazepine Screen, Random, Urine
  • Uses high-resolution accurate mass spectrometry to identify 27 different benzodiazepines and metabolites (including clobazam, zolpidem, and all commonly prescribed benzodiazepines) where immunoassays are not adequate.
  • Detects spiked specimens.
  • Results reported with interpretative comments.
• TOSU | Targeted Opioid Screen, Random, Urine
  • Uses high-resolution accurate mass spectrometry to identify 33 different opioids and metabolites (including buprenorphine, codeine, fentanyl, heroin, hydrocodone, hydromorphone, methadone, morphine, naloxone, oxycodone, tapentadol, and tramadol) where immunoassays are not adequate.
  • Detects spiked specimens.
  • Results reported with interpretative comments.
• TSPU | Targeted Stimulant Screen, Random, Urine
  • Uses high-resolution accurate mass spectrometry to identify 11 different stimulants and metabolites (including amphetamines, methylphenidate, ritalinic acid, 3,4-methylenedioxymethamphetamine [MDMA], and PCP) where immunoassays are not adequate.
  • Detects spiked specimens.
  • Results reported with interpretative comments.